These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1557232)

  • 1. Anti-circumsporozoite protein antibodies measure age related exposure to malaria in Kataragama, Sri Lanka.
    Mendis C; Del Giudice G; Gamage-Mendis AC; Tougne C; Pessi A; Weerasinghe S; Carter R; Mendis KN
    Parasite Immunol; 1992 Jan; 14(1):75-86. PubMed ID: 1557232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to epitopes on merozoite and sporozoite surface antigens as serologic markers of malaria transmission: studies at a site in the dry zone of Sri Lanka.
    Ramasamy R; Nagendran K; Ramasamy MS
    Am J Trop Med Hyg; 1994 May; 50(5):537-47. PubMed ID: 7515593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of a serological tool to predict malaria transmission intensity in an elimination setting.
    Dewasurendra RL; Dias JN; Sepulveda N; Gunawardena GS; Chandrasekharan N; Drakeley C; Karunaweera ND
    BMC Infect Dis; 2017 Jan; 17(1):49. PubMed ID: 28068925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms associated with anti-malarial antibody levels in a low and unstable malaria transmission area in southern Sri Lanka.
    Dewasurendra RL; Suriyaphol P; Fernando SD; Carter R; Rockett K; Corran P; Kwiatkowski D; Karunaweera ND;
    Malar J; 2012 Aug; 11():281. PubMed ID: 22905743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody responses to Plasmodium falciparum sporozoite-, liver- and blood-stage synthetic peptides in migrant and autochthonous populations in malaria endemic areas.
    Ferreira-da-Cruz MF; Deslandes DC; Oliveira-Ferreira J; Montenegro-James S; Tartar A; Druilhe P; Daniel-Ribeiro CT
    Parasite; 1995 Mar; 2(1):23-9. PubMed ID: 9137641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naturally Acquired Antibody Responses to Plasmodium vivax and Plasmodium falciparum Merozoite Surface Protein 1 (MSP1) C-Terminal 19 kDa Domains in an Area of Unstable Malaria Transmission in Southeast Asia.
    Wang Q; Zhao Z; Zhang X; Li X; Zhu M; Li P; Yang Z; Wang Y; Yan G; Shang H; Cao Y; Fan Q; Cui L
    PLoS One; 2016; 11(3):e0151900. PubMed ID: 26999435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of naturally acquired antibody responses against the C-terminal processing products of Plasmodium vivax Merozoite Surface Protein-1 under low transmission and unstable malaria conditions in Sri Lanka.
    Wickramarachchi T; Illeperuma RJ; Perera L; Bandara S; Holm I; Longacre S; Handunnetti SM; Udagama-Randeniya PV
    Int J Parasitol; 2007 Feb; 37(2):199-208. PubMed ID: 17055511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody responses to Plasmodium falciparum and P. vivax sporozoites in areas with stable and unstable malaria.
    Del Giudice G; Lambert PH; Mendis K; Pessi A; Tanner M
    Bull World Health Organ; 1990; 68 Suppl(Suppl):191-6. PubMed ID: 2094587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmodium vivax malaria in Sri Lanka: transmission, disease and immunity.
    Carter R; David P; Mendis K
    Parassitologia; 1993 Jul; 35 Suppl():17-8. PubMed ID: 8233604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low immunogenicity of a Plasmodium vivax circumsporozoite protein epitope bound by a protective monoclonal antibody.
    Jones TR; Yuan LF; Marwoto HA; Gordon DM; Wirtz RA; Hoffman SL
    Am J Trop Med Hyg; 1992 Dec; 47(6):837-43. PubMed ID: 1471743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using serological measures to monitor changes in malaria transmission in Vanuatu.
    Cook J; Reid H; Iavro J; Kuwahata M; Taleo G; Clements A; McCarthy J; Vallely A; Drakeley C
    Malar J; 2010 Jun; 9():169. PubMed ID: 20553604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geostatistical modeling of malaria endemicity using serological indicators of exposure collected through school surveys.
    Ashton RA; Kefyalew T; Rand A; Sime H; Assefa A; Mekasha A; Edosa W; Tesfaye G; Cano J; Teka H; Reithinger R; Pullan RL; Drakeley CJ; Brooker SJ
    Am J Trop Med Hyg; 2015 Jul; 93(1):168-177. PubMed ID: 25962770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural human antibody responses to Plasmodium vivax apical membrane antigen 1 under low transmission and unstable malaria conditions in Sri Lanka.
    Wickramarachchi T; Premaratne PH; Perera KL; Bandara S; Kocken CH; Thomas AW; Handunnetti SM; Udagama-Randeniya PV
    Infect Immun; 2006 Jan; 74(1):798-801. PubMed ID: 16369044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential antibody responses to Plasmodium falciparum and P. vivax circumsporozoite proteins in a human population.
    Burkot TR; Graves PM; Wirtz RA; Brabin BJ; Battistutta D; Cattani JA; Maizels RM; Alpers MP
    J Clin Microbiol; 1989 Jun; 27(6):1346-51. PubMed ID: 2666443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Life-spans of human T-cell responses to determinants from the circumsporozoite proteins of Plasmodium falciparum and Plasmodium vivax.
    Zevering Y; Khamboonruang C; Rungruengthanakit K; Tungviboonchai L; Ruengpipattanapan J; Bathurst I; Barr P; Good MF
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6118-22. PubMed ID: 7517041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of synthetic peptides in the study of the antibody response to Plasmodium vivax sporozoites.
    Pessi A; Michel M; Bianchi E; Mendis A; Tougne C; Verdini AS; Lambert PH; Carter R; Mendis K; Del Giudice G
    Am J Trop Med Hyg; 1990 Jan; 42(1):17-23. PubMed ID: 1689124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of malaria transmission in Kataragama, Sri Lanka: a focus for immuno-epidemiological studies.
    Mendis C; Gamage-Mendis AC; De Zoysa AP; Abhayawardena TA; Carter R; Herath PR; Mendis KN
    Am J Trop Med Hyg; 1990 Apr; 42(4):298-308. PubMed ID: 2184688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modern immunological approaches to assess malaria transmission and immunity and to diagnose plasmodial infection.
    Daniel-Ribeiro CT; Oliveira-Ferreira J; Ferreira-Da-Cruz MF
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 5():117-24. PubMed ID: 1342707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sero-epidemiological evaluation of changes in Plasmodium falciparum and Plasmodium vivax transmission patterns over the rainy season in Cambodia.
    Cook J; Speybroeck N; Sochanta T; Somony H; Sokny M; Claes F; Lemmens K; Theisen M; Soares IS; D'Alessandro U; Coosemans M; Erhart A
    Malar J; 2012 Mar; 11():86. PubMed ID: 22443375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and level of antibodies to the circumsporozoite proteins of human malaria parasites, including a variant of Plasmodium vivax, in the population of two epidemiologically distinct areas in the state of Acre, Brazil.
    Kremsner PG; Neifer S; Zotter GM; Bienzle U; Rocha RM; Maracic M; Clavijo P; Nussenzweig RS; Cochrane AH
    Trans R Soc Trop Med Hyg; 1992; 86(1):23-7. PubMed ID: 1373529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.